✦ LIBER ✦

Reasons for Discontinuation of Omalizumab Therapy in the Treatment of Patients With Moderate to Severe Persistent Asthma

✍ Scribed by SHEINKOPF, L; RAFI, A; DO, L; KLAUSTERMEYER, W; KATZ, R

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effectiveness of omalizumab in reducing

✍ Karpel, Jill; Massanari, Marc; Geba, Gregory P.; Kianifard, Farid; Inhaber, Neil 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 248 KB

Factors predictive of response to omaliz

✍ Wenzel, Sally; Bousquet, Jean; Freeman, Peter; Fox, Howard 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 138 KB

Efficacy and safety of omalizumab in an

✍ Ken OHTA; Terumasa MIYAMOTO; Taro AMAGASAKI; Manabu YAMAMOTO; on behalf of the 1 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 392 KB

A 4 years follow up in children with mod

✍ C.E. Baena-Cagnani; A. Teijeiro; H. Badellino; M.E. Zernotti; G.W. Canonica; V.H 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Patient-reported reasons for the discont

✍ Yeung, Howa; Wan, Joy; Van Voorhees, Abby S.; Callis Duffin, Kristina; Krueger, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 144 KB

THE SAFETY OF OMALIZUMAB THERAPY IN A PA

✍ Antonicelli, Leonardo; Stagnozzi, Giorgia; Giuliodoro, Simona; Abbruzzetti, Ales 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 60 KB